Liquidia - Kapitalisasi Buku LQDA

Logo perusahaan publik Liquidia (LQDA)

Liquidia Corporation (LQDA) focuses on developing innovative drug delivery methods for the treatment of severe lung pathologies, leveraging patent-protected inhalation solutions. However, the business faces threats from patent disputes, reliance on a single drug, and potential delays in FDA reviews. The linear price action on this chart, where the indicator stands at 0.19, is supplemented by data regarding the search for alternative contractors to minimize production disruptions.

LQDA Kapitalisasi Buku Liquidia Inc. (04.07.2022 - 28.10.2026)

Rincian metrik lan analitis perusahaan Liquidia (LQDA)

- rega lan prakiraan konsensus rega:
Kurs saham Liquidia Inc.|LQDA - Prakiraan konsensus analis
- data kapitalisasi pasar:
Kapitalisasi pasar Liquidia Corp|LQDA - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham Liquidia|LQDA - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku liquidia.com|LQDA - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Liquidia Corporation|LQDA - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Liquidia Corp|LQDA - Utang perusahaan|Utang marang nilai buku Liquidia Corp|LQDA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Liquidia
Pambiji fundamental:LQDA - Liquidia Inc.
Barang unggulan Liquidia Corp

The high commercial potential of Liquidia Corporation (LQDA) innovative inhalation drugs necessitates constant monitoring of its financial foundation's stability. By analyzing the organization's balance sheet capitalization, investors track net asset value trends, which allows for a real-time assessment of capital protection and the mitigation of low return on investment risks without waiting for the publication of quarterly reports.

Analisis pesaing Liquidia Corporation

HLN - Kapitalisasi Akuntansi|KVUE: Kapitalisasi Buku|VRNA (veronapharma.com) - Kapitalisasi Buku|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|glpg.com - Kapitalisasi Buku|Nilai Buku Perusahaan ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Nilai Akuntansi Perusahaan|AMPH (Amphastar) - Nilai Buku Perusahaan|Pacira Corp (PCRX) - Aset Bersih Perusahaan|SPRY (ARS Pharmaceuticals) - Kapitalisasi Buku|Kapitalisasi Buku theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan SCPH (scpharmaceuticals.com)|TECX: Nilai Buku Perusahaan|TNXP - Ekuitas Perusahaan|Aset Bersih Perusahaan SXT China SXTC|EPRX - Total Aset Bersih|Kapitalisasi Buku BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku ORMP (Oramed)|Ekuitas Perusahaan ENTX|MindWalk Holdings (HYFT) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan ABVC (abvcpharma.com)|Nilai Buku Perusahaan Cumberland Pharmaceuticals Inc. CPIX|Nilai Buku Perusahaan Quantum BioPharma Ltd. QNTM|Kapitalisasi Buku FGEN (FibroGen Corp)|TELO: Pambiji Buku Bisnis|Nilai Buku Perusahaan RANI (ranitherapeutics.com)|Nilai Buku Bisnis Synergy CHC|RLYB (Rallybio Corp) - Aset Bersih Perusahaan|Kapitalisasi Buku Lexaria|PULM (Pulmatrix Corp) - Kapitalisasi Buku|Pambiji Buku Bisnis ftzy.com.cn (PTHL)|APM - Kapitalisasi Buku|Kapitalisasi Akuntansi lyratherapeutics.com LYRA|Kapitalisasi Buku IBO (Impact BioMedical Inc)|TNFA - Pambiji Buku Bisnis|YCBD: Kapitalisasi Buku|Kapitalisasi Buku PainReform Corp|CYTO - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan lipella.com|Kapitalisasi Buku OPTN (OptiNose)|Aset Bersih Perusahaan PIRS (Pieris Pharmaceuticals Inc)|PROC: Nilai Buku Perusahaan|Petros Pharma - Ekuitas Perusahaan|Nilai Buku Perusahaan Qilian International (QLI)|SLRN: Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan TFF Pharmaceuticals, Inc. (TFFP)